Buy GSK Consumer, target of Rs 781: KRChoksey

3808 Investors following GlaxoSmith Con. Share this News with them.

0

Like this story, share it with millions of investors on M3

Buy GSK Consumer, target of Rs 781: KRChoksey

KRChoksey Research has recommended a buy rating on GlaxoSmithKline Consumer Healthcare with a 12-month target price of Rs 781. Going forward, the research firm believes the company is expected to see strong performance driven by leveraging its flagship brand Horlicks and aggressive plans of new launches.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Buy Pidilite Industries, target of Rs 195: SKP Securities HCL Technologies an underperformer: Karvy Buy Welspun Gujarat, target of Rs 592: HDFC Securities Buy HT Media, target of Rs 165: Kotak Institution Buy Cairn India, target of Rs 302: Citigroup ALSO READ See previous views by KRChoksey See what other Experts & Brokerages are saying about GlaxoSmith Con See messages about GlaxoSmith Con GlaxoSmith Con BSE | NSE 28/05/12 Are Mutual Funds betting on GlaxoSmith Con?

KRChoksey Research has recommended a buy rating on GlaxoSmithKline Consumer Healthcare with a 12-month target price of Rs 781 in its September 19, 2008 research report. "At the CMP of Rs 619, the stock is trading at 14.4x TTM EPS of Rs 43.0. Going forward, we believe the company is expected to see strong performance driven by leveraging its flagship brand Horlicks and aggressive plans of new launches. We initiate coverage on the stock with a Buy rating and a 12-month target price of Rs 781, implying an upside potential of 26% which is arrived by discounting CY09E EPS of Rs 52 by 15x," says KRChoksey's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......